Haematologica (Jul 2024)
Excellent outcome of children/adolescents with primary mediastinal large B-cell lymphoma treated with FAB/LMB-based chemotherapy regimen with rituximab
- Marie Emilie Dourthe,
- Anne Auperin,
- Charlotte Rigaud,
- Melissa Barbati,
- Jacinthe Bonneau,
- Nimrod Buchbinder,
- Marie-Laure Couec,
- Peggy Dartigues,
- Stéphane Ducassou,
- Nathalie Garnier,
- Stéphanie Haouy,
- Bénédicte Jonca,
- Anne Jourdain,
- Amaury Leruste,
- Thierry Molina,
- Françoise Montravers,
- Marlène Pasquet,
- Aurélie Phulpin,
- Maryline Poirée,
- Mathieu Simonin,
- Alexandra Spiegel,
- Arnauld Verschuur,
- Thierry Leblanc,
- Judith Landman-Parker,
- Catherine Patte,
- Véronique Minard-Colin
Affiliations
- Marie Emilie Dourthe
- Department of Pediatric Hematology and Immunology, Robert Debré University Hospital, AP-HP and University de Paris, Paris, France; Université Paris Cité, Institut Necker-Enfants Malades (INEM), Institut national de la santé et de la recherche médicale (Inserm) U1151, Paris
- Anne Auperin
- Service de Biostatistique et d'Epidémiologie, Gustave Roussy Cancer Campus, INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif
- Charlotte Rigaud
- Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif
- Melissa Barbati
- Department of Pediatric Oncology and Haematology, University Hospital of Lille, Lille
- Jacinthe Bonneau
- Department of Pediatric Oncology and Haematology, University Hospital of Rennes, Rennes
- Nimrod Buchbinder
- Department of Pediatric Oncology and Haematology, University Hospital of Rouen, Rouen
- Marie-Laure Couec
- Pediatric hematology and oncology department, University Hospital of Nantes, Nantes
- Peggy Dartigues
- Department of Biopathology, Morphology Unit, Gustave Roussy, Université Paris Saclay, Villejuif
- Stéphane Ducassou
- Department of Pediatric Oncology and Haematology, University Hospital of Bordeaux, Bordeaux
- Nathalie Garnier
- Institut d'Hématologie et d'Oncologie Pédiatrique, Hospices Civils de Lyon, Lyon
- Stéphanie Haouy
- Department of Pediatric Oncology and Haematology, University Hospital of Montpellier, Montpellier
- Bénédicte Jonca
- Department of nuclear medicine, University Hospital Tenon, Paris
- Anne Jourdain
- Department of Pediatric Oncology and Haematology, University Hospital of Tours, Tours
- Amaury Leruste
- SIREDO Oncology Center, Institut Curie, PSL Research University, Paris
- Thierry Molina
- Department of biopathology, University Hospital Necker Enfants Malades, Université Paris Cité, Paris
- Françoise Montravers
- Department of nuclear medicine, University Hospital Tenon, Paris
- Marlène Pasquet
- Department of Pediatric Oncology and Haematology, University Hospital of Toulouse, Toulouse
- Aurélie Phulpin
- Pediatric Oncology and Hematology Department, University Hospital of Nancy (CHRU Nancy), Nancy
- Maryline Poirée
- Department of Pediatric Oncology and Haematology, University Hospital of Nice, Nice
- Mathieu Simonin
- Pediatric Hematology Oncology Department, Sorbonne Université/Trousseau Hospital, APHP, Paris
- Alexandra Spiegel
- Pediatric Hematology Oncology Department, University Hospital of Strasbourg, Strasbourg
- Arnauld Verschuur
- Department of Pediatric Hematology Immunology and Oncology, La Timone Hospital, APHM, Marseille
- Thierry Leblanc
- Department of Pediatric Hematology and Immunology, Robert Debré University Hospital, AP-HP and University de Paris, Paris
- Judith Landman-Parker
- Pediatric Hematology Oncology Department, Sorbonne Université/Trousseau Hospital, APHP, Paris
- Catherine Patte
- Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif
- Véronique Minard-Colin
- Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France; INSERM Unité 1015
- DOI
- https://doi.org/10.3324/haematol.2024.285403
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
